未登录

Z

Zhangyi Luo

University of Pennsylvania

H指数:15

被引数:703

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted lipid nanoparticles unlock in vivo human haematopoietic stem cell gene editing

靶向脂质纳米颗粒解锁体内人造血干细胞基因编辑

Nature Biomedical Engineering

IF26.6

2026-08-210

PRE

GAS6-inhibiting multi-functional nanoparticles for enhanced cancer therapy

用于增强癌症治疗的GAS6-inhibiting多功能纳米颗粒

Journal of Pharmaceutical Analysis

IF8.9

2026-05-120

OAAI

Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy

前体药物栓系脂质纳米粒用于协同信使RNA癌症免疫治疗

Nature Nanotechnology

IF34.9

2026-03-180

PRE

Dual switches ignite tumour-specific mRNA therapeutics

双开关点燃肿瘤特异性mRNA疗法

Nature Nanotechnology

IF34.9

2025-11-120

PRE

Improving Tumor Targeting and Penetration for Nanoparticle-Mediated Cancer Therapy

提高纳米粒介导癌症治疗中的肿瘤靶向性与穿透性

IF9.1

2025-03-091

OA

YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy

BIOMACROMOLECULES

IF5.4

2024-12-070

PRE

Delivery of PARP inhibitors through 2HG-incorporated liposomes for synergistically targeting DNA repair in cancer

IF10.1

2024-11-010

PRE

Advanced Hierarchical Computational Modeling-Based Rational Development of Platinum (II) Nanocomplex to Improve Lung Cancer Therapy

ADVANCED FUNCTIONAL MATERIALS

IF19

2024-09-270

PRE

In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy

ADVANCED SCIENCE

IF14.1

2024-03-142

OA

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

NATURE COMMUNICATIONS

IF15.7

2024-01-0413

OAAI

Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy

靶向癌症代谢途径改善化疗和免疫治疗

IF10.1

2023-10-0116

OAAI

Improved antitumor activity against prostate cancer via synergistic targeting of Myc and GFAT-1

通过Myc和GFAT-1的协同靶向改善对前列腺癌的抗肿瘤活性

IF13.3

2023-01-0112

OAAI

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

NATURE NANOTECHNOLOGY

IF34.9

2022-11-2457

OA

Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages

ACTA PHARMACEUTICA SINICA B

IF14.6

2022-03-0135

OAAI

Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2021-12-018

OAAI

A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death

IF12.9

2021-03-0118

OAAI

Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer

IF12.9

2021-02-0141

OAAI

Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy

由基于吉西他滨的小载体共同递送的三联药物用于胰腺癌免疫化疗

ACTA BIOMATERIALIA

IF9.6

2020-04-0134

OAAI

Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer

ACTA BIOMATERIALIA

IF9.6

2020-03-0138

OAAI

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

IF13.3

2020-01-0131

OAAI